血液恶性瘤患者的症状,症状概况和医疗保健利用:一项回顾性观察队列研究和潜在类分析
Reanne Booker1,2, Richard Sawatzky3,4,5, Aynharan Sinnarajah6
1Palliative Care, Arthur JE Child Comprehensive Cancer Centre, Calgary, AB T2N 4N1, Canada.
Current oncology (Toronto, Ont.)
|February 25, 2025
概括
患有血液性恶性瘤的患者经历了高症状负担,经常报告四个或更多同时出现的症状. 有效的症状管理和支持对于改善这些患者的生活质量至关重要.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 抚慰性护理是一种缓解性护理.
背景情况:
- 症状负担显著影响患有血液性恶性瘤的患者的生活质量.
- 了解症状概况对于全面的患者护理至关重要.
研究的目的:
- 为了探索患有血液性恶性瘤的患者的症状患病率,严重程度和概况.
- 调查症状概况与人口,临床和治疗变量之间的关联.
- 检查生命的最后一年期间的症状和医疗保健利用情况.
主要方法:
- 对6136名患有血液性恶性瘤的患者进行了回顾性观察队列研究,完成了患者报告的结果测量.
- 审查急诊室的访问和住院的情况.
- 对432名在结局测量完成后一年内死亡的患者进行图表审计.
主要成果:
- 超过50%的患者报告了四种或更多同时出现的症状.
- 疲劳,健康状况下降和昏昏欲睡是最常见的症状.
- 症状概况与人口统计学,临床因素和医疗保健利用,特别是急诊室访问有关.
结论:
- 血液性恶性瘤患者面临着相当大的症状负担,通常有多个同时出现的症状.
- 症状概况与患者的特征和医疗保健使用有关.
- 对这种患者群体来说,急需加强对症状管理的支持.
更多相关视频
03:40Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
877
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.1K
相关概念视频
Bone Marrow Sampling and Transplants
274
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
274
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
Disorders of Leukocytes
833
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
833
